openRxiv

What openRxiv does

openRxiv is an independent nonprofit organization incorporated in California and headquartered in Davis, CA. Formed in March 2025, it serves as the organizational home for bioRxiv (founded 2013) and medRxiv (founded 2019), the two leading preprint servers for the life and health sciences, which together host more than 339,000 preprints from researchers in 170+ countries and receive approximately 10 million abstract views and 4 million PDF downloads per month.

The core platform processes JATS-format XML content, assigns DOIs through Crossref under openRxiv's own prefix (10.64898), and manages a manuscript submission-to-posting workflow that typically completes within 48–72 hours. Around the core hosting infrastructure, openRxiv operates an integration ecosystem: B2J/M2J pipelines connect preprints to 300+ journals and independent peer review services; B2X pipelines route preprints to third-party AI review tools (Reviewer3, q.e.d. Science) and data repositories (Dryad); Hypothesis powers article-level commenting; SciScore and Sciety supply resource and trust signals. openRxiv Labs, launched in June 2026, functions as a structured experimental program with three planned 2026 initiatives, the first being a Curvenote-developed interactive reader.

openRxiv operates on a freemium model with no fees to authors or readers and has never charged article-processing charges. Funding comes from diversified philanthropic sources, anchored by a three-year Chan Zuckerberg Initiative seed grant and including the Sergey Brin Family Foundation, Simons Foundation, HHMI, and the Gates Foundation. The organization is governed by a six-member board chaired by Scott Fraser (CZI) and includes co-founders Richard Sever (Chief Science and Strategy Officer) and John Inglis (Chair of the Scientific and Medical Advisory Board), with Tracy Teal serving as inaugural CEO since August 2025.

Name

openRxiv

Legal name

openRxiv

Website

https://openrxiv.org

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

openRxiv is an independent nonprofit operating bioRxiv and medRxiv, the world's largest free preprint servers for life and health sciences, serving over 339,000 research preprints from 170+ countries with rapid 48–72 hour posting.

Ownership category

akta.pro rank

Product category

Scientific Preprint Platform

NAICS

Software Publishers (5132)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)

akta.pro secondary industry

Open Access Scholarly Journals & Monographs (EDAGAFAJ)

Keywords

• Preprint servers
• Biomedical research hosting
• Scientific manuscript platform
• Research communication infrastructure
• Open access publishing

Headquarters

HQ city

Davis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Philanthropic/Foundation Funding: openRxiv operates as an independent nonprofit with diversified funding from foundations, philanthropists, and community support. Major funders include Chan Zuckerberg Initiative (provided three-year seed funding for launch), with additional support from the Sergey Brin Family Foundation and others.
2. Donations and Community Support: The organization accepts donations and community support to ensure financial sustainability. Operating costs are kept minimal compared to journal APCs, with costs two orders of magnitude lower than traditional journal publishing.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

openRxiv operates free, open-access preprint servers—bioRxiv (biological sciences) and medRxiv (health sciences)—that allow researchers worldwide to post scientific manuscripts within 48-72 hours of submission and before formal journal peer review. The nonprofit also runs openRxiv Labs, an experimental program developing new research communication tools including Curvenote Reader for interactive preprint exploration, and provides submission pipelines connecting preprints to 300+ journals and AI review services.

Product overview

openRxiv is an independent nonprofit organizational home for two core preprint servers: bioRxiv (biological sciences, 273,956+ articles) and medRxiv (health sciences, 65,414+ articles). These platforms enable researchers to share scientific findings immediately and freely before formal peer review. The organization operates additional products including B2X/M2X pipelines connecting preprints to over 300 journals and external author services, and openRxiv Labs (an experimental space for new research communication approaches). External AI-powered author services integrated via pipelines include Reviewer3 (automated manuscript review) and q.e.d. Science (AI manuscript analysis). Curvenote Reader provides interactive preprint reading. All preprints receive DOIs via Crossref. The portfolio works as a unified ecosystem: the core preprint servers host content, pipelines enable downstream submission and review services, and Labs drives innovation for future capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• bioRxiv: Preprint server for biological sciences, enabling researchers to share findings before journal peer review.
• medRxiv
• openRxiv Labs

Products and services

• bioRxiv A free preprint server for biological sciences, enabling researchers worldwide to share scientific findings immediately before formal journal peer review. Hosts 273,956+ articles with approximately 7 million abstract views and 4 million PDF downloads per month.
• medRxiv A free preprint server for health sciences and medical research, enabling clinical researchers and health professionals to share findings before formal peer review. Hosts 65,414+ articles and played a critical role during the COVID-19 pandemic as a rapid distribution channel for emerging medical information.
• openRxiv Labs An experimental space within openRxiv for testing new and ambitious approaches to research communication on top of the corpus of preprints, figures, metadata, and other research outputs. Works with partners to run bold, high-impact experiments with predefined hypotheses, goals, success metrics, and defined durations.
• Curvenote Reader An interactive preprint reading experience developed in partnership with Curvenote and available in openRxiv Labs. Offers readers the ability to explore references, terminology, expanded figures, and related works while staying in context of the original preprint. Initially covers bioRxiv preprints with medRxiv support planned.
• B2J/M2J Journal Submission Pipelines A pipeline connecting bioRxiv and medRxiv to traditional peer-reviewed journals, enabling authors to submit preprints directly to over 300 journals and independent peer review services. The pipeline streamlines the path from preprint posting to formal publication while maintaining a single DOI across all versions.

Quantifiable outcome

• 80% of preprints ultimately published in peer-reviewed journals, demonstrating integration with traditional publishing ecosystem
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered flagship and core.

• CurvenoteflagshipTechnology or Integration · 1 June 2026First openRxiv Labs experiment partner. Developed Curvenote Reader enabling interactive preprint reading experience with exploration of references, figures, and related works. Processes JATS-format XML into Open Exchange Architecture (OXA) format.
• q.e.d. SciencecoreTechnology or Integration · 6 November 2025AI-powered manuscript review platform pilot. Uses generative AI to analyze claims and data, identify gaps, and provide structured feedback reports to authors within 30 minutes. Integrated via B2X pipeline accessible from bioRxiv author area.
• DryadcoreTechnology or Integration · 18 September 2025Integration connecting bioRxiv/medRxiv submission system to Dryad data portal. Authors deposit datasets linked to preprints without redundant metadata entry. Curated datasets display verified checkmark on preprint pages. Available on both bioRxiv and medRxiv.
• HypothesiscoreTechnology or Integration · 1 January 2017Long-standing partnership since 2017 for article-level commenting. Hypothesis replaced Disqus as commenting platform in 2026. Includes author email notifications for new comments. Available on all bioRxiv and medRxiv categories.
• Howard Hughes Medical Institute (HHMI)coreStrategic or Co-development PartnerMajor biomedical funder requiring grantees to post preprints (initial and revised versions). Named bioRxiv and medRxiv among recommended non-profit servers. Aligns with Plan U proposal for universal free access to research.
• PREreviewcoreStrategic or Co-development PartnerOpen platform for preprint peer review. Community initiative training early-career researchers in peer review. TAP program (Transparent and Accountable Peer Review) uses bioRxiv/medRxiv preprints for training exercises.
• Yale University School of MedicinecoreStrategic or Co-development PartnerCo-founder partner of medRxiv (2019) alongside Cold Spring Harbor Laboratory and BMJ. Yale researchers Harlan Krumholz and Joseph Ross co-founded medRxiv. Krumholz serves on openRxiv board.
• BMJ GroupcoreStrategic or Co-development PartnerHealthcare knowledge provider and co-founder partner of medRxiv (2019). Theodora Bloom and Claire Rawlinson from BMJ developed medRxiv's preprint policies and screening protocols.
• Gates FoundationcoreStrategic or Co-development PartnerMajor philanthropist funder requiring grantees to post manuscripts as preprints. Implementing Plan U proposal for universal free access to research findings.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ChemRxiv: ChemRxiv is a preprint server for chemistry launched by the American Chemical Society in collaboration with several societies. It operates an equivalent free, community-led preprint model for chemistry research, making it a direct category peer to bioRxiv.
• Research Square: Research Square is a preprint platform owned by Springer Nature that hosts preprints across life sciences, health sciences, and medicine. It competes directly with bioRxiv and medRxiv for biomedical preprint submissions and offers in-house AI review services similar to openRxiv's B2X integrations.
• Preprints.org: Preprints.org is a multidisciplinary preprint server operated by MDPI covering biology, medicine, and the sciences. It directly competes with bioRxiv and medRxiv for biomedical preprints with a similar free-to-post, free-to-read model.
• F1000Research: F1000Research is an open research publishing platform with transparent peer review, published by Taylor & Francis. It overlaps with openRxiv's mission of accelerating scientific communication and offers preprint-style posting with open peer review, making it a closely comparable alternative model.
• SSRN: SSRN (Social Science Research Network), owned by Elsevier, is one of the largest preprint and early-stage research repositories in the world. It functions as a direct peer to openRxiv in the preprint-server category, though primarily covering social sciences and humanities rather than biomedicine.
• arXiv: Founded in 1991 at Cornell, arXiv is the original preprint server for physics, mathematics, computer science, and related fields. It is the most directly comparable preprint platform to openRxiv's bioRxiv and medRxiv, operating under a similar free, community-led model for scholarly preprints.

Broad incumbents

• eLife: eLife is a nonprofit open access journal in life sciences and medicine known for its consultative peer review. It shares openRxiv's nonprofit, researcher-led ethos and is a key downstream integration partner in the publishing ecosystem.
• PLOS: PLOS is a leading open access publisher across multiple life sciences and medicine journals. It is a broader incumbent in open scientific publishing with overlapping mission but specialized in formal peer-reviewed journals rather than preprints.
• Europe PMC: Europe PMC is a European-based biomedical literature repository including preprints, abstracts, and full-text articles, funded by funders including the Wellcome Trust and EMBO. It overlaps with medRxiv's health sciences preprint hosting as part of a broader repository service.

Others

• Zenodo: Zenodo is a general-purpose open research data and publication repository hosted by CERN, supporting datasets, software, and preprints across all disciplines. It is an adjacent infrastructure provider rather than a direct competitor to bioRxiv/medRxiv's specialized biomedical preprint focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• GitHubgithub.com/openrxivlabs/curvenote-reader
• LinkedInlinkedin.com/company/openrxiv
• Xx.com/openrxiv

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about openRxiv